Invariably preceding the development of overt type 2 diabetes, there is a decrease in systemic insulin sensitivity referred to as insulin resistance, which is also a feature of chronic inflammatory conditions in non-diabetics. This evidence concerns the gene INS and type 2 diabetes mellitus.